Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A

Clinical trial NCT04069533 · UNKNOWN

Trial details

NCT number: NCT04069533
Sponsor: Rocket Pharmaceuticals Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Fanconi Anemia Complementation Group A

Start date: 2019-11-28
Primary completion: 2025-02-01
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.